Influenza, Human: all 2,264 studies
Page 19 of 23. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.
- Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected AdultsCompletedNCT01155037Phase 2
- Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly SubjectsCompletedNCT01151059Phase 2
- Studies of Avian Influenza Transmission to Humans in EgyptCompletedNCT01150552
- Evaluating Modes of Influenza Transmission Between HumansWithdrawnNCT01150149Not applicable
- Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011CompletedNCT01147081Phase 3
- FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health RecordCompletedNCT01146899Not applicable
- Interferon Alpha Lozenges Plus Oseltamivir for Influenza TreatmentCompletedNCT01146535Phase 2
- Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement TherapyWithdrawnNCT01146353
- Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)CompletedNCT01146119Phase 2
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 SeasonCompletedNCT01146015Phase 3
- Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy AdultsCompletedNCT01142362Phase 1
- Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011CompletedNCT01140009Phase 2
- Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)CompletedNCT01138397Phase 3
- Blood and Plasma Collection For Use in Future Clinical TrialsCompletedNCT01136057
- Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During LactationCompletedNCT01130636Phase 4
- The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus AStatus unknownNCT01127282Phase 4
- Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese VolunteersCompletedNCT01123954Phase 2
- Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)CompletedNCT01121822Phase 3
- Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza VaccinesStatus unknownNCT01119157Phase 4
- Evaluation of Pandemic Influenza A (H1N1)Candidate VaccinesCompletedNCT01111968Phase 1
- Avian Influenza Studies In LebanonCompletedNCT01107262
- The Role of Influenza as a Trigger for Acute Myocardial Infarction: a CALIBER StudyCompletedNCT01106196
- Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived VaccineCompletedNCT01101074
- Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in ChildrenCompletedNCT01100294Not applicable
- Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA VaccineCompletedNCT01098786
- Effect of Age and Prior Immunity on Response to H1N1 Vaccines in ChildrenWithdrawnNCT01097941Phase 4
- Follow-up of Immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers After 6 MonthsStatus unknownNCT01096238
- Immunogenicity Study of S-OIV H1N1 Influenza VaccineStatus unknownNCT01096225
- Rapid Diagnostic Test for InfluenzaCompletedNCT01089816
- A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy AdultsCompletedNCT01089660Phase 2
- Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar LavageCompletedNCT01089400
- An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...CompletedNCT01086657Phase 1
- Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 VaccinesCompletedNCT01086566Phase 1
- Collection and Extraction of Respiratory SpecimensCompletedNCT01083511
- Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy SubjectsCompletedNCT01079273Phase 4
- The Chloroquine for Influenza Prevention TrialStatus unknownNCT01078779Phase 2
- Dose Finding Study of Single Dose GHB11L1 in Healthy AdultsCompletedNCT01078701Phase 2
- Host Genetic Susceptibility to Avian Influenza A/H5N1CompletedNCT01074736
- Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) VaccineCompletedNCT01072799Phase 2
- Auto-immunity in Lupus Patients After Influenza VaccineCompletedNCT01072734Phase 2
- Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu)CompletedNCT01069874Phase 2/3
- Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly SubjectsCompletedNCT01069367Phase 4
- TIV Infant/Toddler Response Evaluation (TITRE)- Follow-up & Focus on Influenza BStatus unknownNCT01067404
- PRIMAGE (Probiotics, Immunity and Ageing)Status unknownNCT01066377Not applicable
- Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 InfluenzaCompletedNCT01066169
- Vaccination Against Influenza in Autoimmune DiseasesCompletedNCT01065285Phase 4
- Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With InfluenzaWithdrawnNCT01063933Phase 1/2
- Adult Safety Study of 2009/2010 Seasonal Influenza VaccineCompletedNCT01063088Phase 3
- Respiratory Virus Outpatient Study (FLU 002 Plus)CompletedNCT01056354
- Respiratory Virus Hospitalization Study (FLU 003 Plus)CompletedNCT01056185
- Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 PatientsStatus unknownNCT01055990Phase 2
- A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 InfluenzaStatus unknownNCT01053533Not applicable
- A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing HomesStatus unknownNCT01053377Phase 4
- Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in IndiaCompletedNCT01053143Phase 3
- A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With InfluenzaCompletedNCT01052961Phase 4
- Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and AdolescentsCompletedNCT01052402Phase 1/2
- Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination DeviceCompletedNCT01049490Not applicable
- Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months InfantsCompletedNCT01047202Phase 4
- Virus Shedding and Environmental Deposition of a Novel Influenza VirusCompletedNCT01046734
- Novel Influenza A (H1N1) Surveillance RegistryCompletedNCT01046331
- Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) ExposureWithdrawnNCT01045564Phase 2
- Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in ChinaCompletedNCT01044316Phase 3
- Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza VirusCompletedNCT01044095Not applicable
- Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived VaccineCompletedNCT01040741
- Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 MonthStatus unknownNCT01040078Phase 3
- Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected PatientsCompletedNCT01039220Not applicable
- Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit VaccineCompletedNCT01037855
- Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety StudyCompletedNCT01037829
- Safety and Efficacy of Oseltamivir in Children Younger Than One Year of AgeWithdrawnNCT01037634Phase 2
- Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed InfluenzaCompletedNCT01037205Phase 2
- Field Trial of Maternal Influenza Immunization in AsiaCompletedNCT01034254Phase 3
- Collaborative H1N1 Adjuvant Treatment Pilot TrialTerminatedNCT01033955Phase 2
- Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and AdultsCompletedNCT01032980
- Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 InfectionCompletedNCT01032408Phase 3
- Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes MellitusCompletedNCT01032395Phase 3
- Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid TumorsCompletedNCT01031719Phase 3
- Safety and Efficacy of Oral Colostrum Derived Anti Influenza Antibodies in Healthy VolunteersStatus unknownNCT01026350Phase 1
- Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in ChinaCompletedNCT01025544Phase 3
- Evaluation of Pandemic Vaccination CampaignCompletedNCT01024725
- Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)CompletedNCT01024673
- Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant WomenCompletedNCT01024400Phase 2
- Efficacy Safety Study of Flu Vaccine in Immunodepression PatientsCompletedNCT01022749Phase 3
- Acute Respiratory Infection ConsortiumActive, not recruitingNCT01021098
- Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and BiologicsStatus unknownNCT01019837Not applicable
- Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of AgeCompletedNCT01019772Phase 3
- Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on ChemotherapyCompletedNCT01016548Phase 3
- Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older AdultsCompletedNCT01014806Phase 2
- Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 FluTerminatedNCT01014364Phase 3
- Immunogenicity and Safety of a Cell-derived Influenza Vaccine in ElderlyCompletedNCT01013675Phase 2
- H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant WomenCompletedNCT01012557Not applicable
- Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal InfluenzaCompletedNCT01011582
- Tolerability and Immunogenicity of Fluval P Monovalent Influenza VaccineCompletedNCT01010893Not applicable
- A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly VolunteersCompletedNCT01010737Phase 1/2
- Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICUTerminatedNCT01010087Phase 2
- Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in AdultsWithdrawnNCT01008956Phase 2
- Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart TransplantationStatus unknownNCT01008683
- Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, AdultsCompletedNCT01008137Phase 4
- Effects of Tea Catechin Consumption on the Prophylaxis of Influenza InfectionCompletedNCT01008020Not applicable
- Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric PopulationCompletedNCT01007201Not applicable
- Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1CompletedNCT01006798Phase 1